Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Featuring perspectives from Prof Claire Harrison and Dr John Mascarenhas, including the following topics:

Introduction (0:00)

• New Biology of Myelofibrosis (1:55)
• Novel Regulatory T-Cell Infusion Therapy (14:57)
• Myelofibrosis 2025: JAK Inhibitors (Ruxolitinib) (20:39)
• BET Inhibitors: Pelabresib (42:03)
• Navtemadlin (53:20)

CME information and select publications